NephroPlus files DRHP, to raise ₹353.4 cr fresh capital from IPO
The Hindu
NephroPlus files for IPO to raise funds for expansion, with plans to open new dialysis clinics in India.
Mines Ministry to auction 19 critical mineral blocks on March 23, expanding strategic resources for clean energy and technology sectors.
Five top firms lose ₹1 lakh crore in market value, with HDFC Bank experiencing the largest decline of ₹56,124.48 crore.
HDFC Bank terminates three senior officials over client onboarding issues at its DIFC branch amid ethical concerns following chairman's resignation.
Air India CEO warns of potential flight cuts and reduced travel demand due to rising fuel costs amid ongoing Gulf conflict.
Options are widely used by retail traders to speculate on the value of the stock for immediate gains and such behaviour in large scale can distort the market
India achieves 1 billion tonne coal production for the second consecutive year, ensuring stable energy supply and economic growth.
Generic drugmakers in India launch affordable Semaglutide versions, targeting a $1 billion diabetes and weight loss market.
Indian and Asian refiners eye Iranian oil purchases as U.S. waives sanctions amid energy crisis linked to the Iran-Israel war.
Iran war impacts pesticide prices, warning of a 20-25% rise and increased risk of counterfeit products during the kharif season.
India's forex reserves fell by $7 billion to $709.76 billion, according to RBI data for the week ending March 13.
Natco Pharma will launch its Semaglutide injection (multi dose vials) in the domestic market on Saturday.
Flipkart announces a 105% bonus payout for 2025, rewarding employees for strong growth and performance metrics.
Core sector growth in India plummeted to 2.3% in February, amid declining domestic production and impending West Asia crisis impacts.